Online inquiry

IVTScrip™ mRNA-Human APLP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26712MR)

This product GTTS-WK26712MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the APLP2 protein. This product can be used in Microglial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001142276.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 334
UniProt ID Q06481
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human APLP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK26712MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK24640MR IVTScrip™ mRNA-Human APOPT1, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA APOPT1
GTTS-WK20423MR IVTScrip™ mRNA-Human AHNAK2, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA AHNAK2
GTTS-WK2102MR IVTScrip™ mRNA-Human Synaptophysin, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA Synaptophysin
GTTS-WK22012MR IVTScrip™ mRNA-Human ARHGEF19, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF19
GTTS-WK13093MR IVTScrip™ mRNA-Human ADAM22, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADAM22
GTTS-WK25391MR IVTScrip™ mRNA-Human ASAP1, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ASAP1
GTTS-WK10701MR IVTScrip™ mRNA-Human ADAMTS17, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADAMTS17
GTTS-WK21505MR IVTScrip™ mRNA-Human ANKRD18DP, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD18DP
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →